Loading...
Loading...
India's valsartan imports from UNITED STATES total $1.9M across 248 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $1.1M in import value; the top 5 suppliers together control 89.8% of this origin. Leading Indian buyers include IPCA LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for valsartan — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Valsartan supplier from UNITED STATES to India, with import value of $1.1M across 15 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, NEWLIFE MEDICALS (USA). INC, AMSTERDAM PHARMA APTEKA RX INC, AMSTERDAM PHARMA (APTEKA RX INC.), AGRACE PHARMA. — collectively account for 89.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $1.1M | 15 | 60.6% |
| 2 | NEWLIFE MEDICALS (USA). INC | $467.3K | 9 | 24.8% |
| 3 | AMSTERDAM PHARMA APTEKA RX INC | $34.6K | 11 | 1.8% |
| 4 | AMSTERDAM PHARMA (APTEKA RX INC.) | $26.0K | 7 | 1.4% |
| 5 | AGRACE PHARMA. | $22.9K | 3 | 1.2% |
| 6 | REGIONAL PHARMACY | $19.2K | 9 | 1.0% |
| 7 | AMNEAL PHARMACEUTICALS OF LLC | $17.7K | 63 | 0.9% |
| 8 | AGRACE PHARMA | $14.8K | 3 | 0.8% |
| 9 | M/S. NEWLIFE MEDICALS (USA).INC | $12.9K | 1 | 0.7% |
| 10 | Espee Biopharma & Finechem LLC | $12.4K | 6 | 0.7% |
| 11 | NEW LIFE MEDICALS USA INC | $12.4K | 3 | 0.7% |
| 12 | GOOD HEALTH PHARMA SUPPLIES | $11.0K | 2 | 0.6% |
| 13 | M/S. NEW LIFE MEDICALS (USA),INC. | $9.7K | 2 | 0.5% |
| 14 | ESPEE BIOPHARMA FINECHEM LLC | $8.6K | 4 | 0.5% |
| 15 | RAFF & HALL PHARMACY | $6.9K | 3 | 0.4% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED | $1.5M | 9 | 81.4% |
| 2 | UNICHEM LABORATORIES LIMITED | $43.1K | 8 | 2.3% |
| 3 | AJANTA PHARMA LIMITED | $39.1K | 17 | 2.1% |
| 4 | LAURUS LABS LIMITED | $35.5K | 10 | 1.9% |
| 5 | INVENTIA HEALTHCARE LIMITED | $28.2K | 3 | 1.5% |
| 6 | DR.REDDY'S LABORATORIES LTD | $24.6K | 4 | 1.3% |
| 7 | ZYDUS LIFESCIENCES LIMITED | $22.7K | 14 | 1.2% |
| 8 | HETERO LABS LIMITED | $20.8K | 3 | 1.1% |
| 9 | MYLAN LABORATORIES LIMITED | $19.7K | 13 | 1.0% |
| 10 | RUBICON RESEARCH PRIVATE LIMITED | $19.0K | 5 | 1.0% |
| 11 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $18.3K | 75 | 1.0% |
| 12 | UMEDICA LABORATORIES PRIVATE LIMITED | $14.2K | 4 | 0.8% |
| 13 | HETERO LABS LIMITED | $12.9K | 7 | 0.7% |
| 14 | CLIANTHA RESEARCH LIMITED | $9.7K | 4 | 0.5% |
| 15 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $9.7K | 2 | 0.5% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Valsartan suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, NEWLIFE MEDICALS (USA). INC, AMSTERDAM PHARMA APTEKA RX INC. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $1.1M USD across 15 shipments. India imported Valsartan worth $1.9M USD from UNITED STATES in total across 248 shipments.
India imported Valsartan worth $1.9M USD from UNITED STATES across 248 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Valsartan sourced from UNITED STATES include IPCA LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, AJANTA PHARMA LIMITED. The largest buyer is IPCA LABORATORIES LIMITED with $1.5M in imports across 9 shipments.
The total value of Valsartan imports from UNITED STATES to India is $1.9M USD, across 248 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
248 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists